Subsequent
inflammation in
stroke plays an important role in the damage of neurons in the perilesional area. Therapeutic intervention targeting
inflammation may be a promising complementary strategy to current treatments of
stroke. Here, we explored the possible beneficial effects of
tyrosol, a derivative of
phenethyl alcohol and natural
antioxidant, playing an anti-inflammatory role in astrocyte culture and in vitro
oxygen glucose deprivation (OGD) model. MTT, western blot, ELISA and EMSA assays were carried out to investigate cell viability,
protein expression level,
cytokine expression and NF-κB activity. We found
tyrosol protected cultured astrocytes against OGD-induced cell viability loss in MTT test. Meanwhile,
tyrosol attenuated the released TNF-α and
IL-6 level from astrocyte via regulating Janus N-terminal
kinase (JNK). The reduction of
cytokines from astrocyte might be due to its inhibition of astrocyte activation and regulation of STAT3 signaling pathway since
tyrosol attenuated the expression level of GFAP (
glial fibrillary acidic protein) and the phosphorylation of STAT3. Additionally, we demonstrated that
tyrosol prevented the degradation of IκBα and the increase of IκBα phosphorylation in astrocytes exposed to OGD, which led to the suppression of NF-κB function during
ischemia. Collectively, our results showed that
tyrosol may be a promising complementary treatment compound for
stroke via modulating the inflammatory response in astrocytes during
ischemia.